←
Kumar Thurimella, MD PhD552 posts
Kumar Thurimella, MD PhD avatar

Kumar Thurimella, MD PhD

@k00kumar

IM TIP Resident @StanfordMed | MD @CUAnschutz, PhD at @BroadInstitute/@Cambridge_Uni,@Gates_Cambridge | former software eng @UberEng

◷ Joined May 2011▧ 41 Photos and videos
Kumar Thurimella, MD PhD avatar
Kumar Thurimella, MD PhD@k00kumar·Feb 20

1/ Our paper is out today in @CellSystemsCP. We used protein language models and deep learning to identify candidate protease allergens in the human microbiome. cell.com/cell-systems/fullte…

Bowen Jing avatar
⟳ Kumar Thurimella, MD PhD retweeted
Bowen Jing@bjing2016·Oct 28

Today, in collaboration with Anthropic, we’re excited to share rapid initial progress towards an antibody treatment for food allergy, which affects over 200 million people worldwide, discovered with the help of Claude. At Divergence Labs, we believe that AI can unlock the next generation of antibody therapeutics with more effective mechanisms than before. Such mechanisms are urgently needed in food allergy, which involve overcoming one of the tightest affinity protein pairs in immunology, IgE and its receptor FcεRI, on mast cells. Treatment with Xolair—the only approved antibody for food allergy—sequesters circulating IgE, but mast cells remain sensitized for weeks to months due to the extraordinarily slow dissociation of IgE from FcεRI. We envision a treatment that actively pulls IgE off of FcεRI, without waiting for natural dissociation. Like picking a lock, this requires the right combination of geometry and force. Our research team, working with Claude, ideated on mechanisms to accomplish this disruption, and converged on an antibody format with two arms with different functions and epitopes. Within one month, we designed, synthesized, and experimentally confirmed the biophysical function of the two arms, which we are now assembling into full therapeutic formats.

0:15
CEB Cambridge avatar
⟳ Kumar Thurimella, MD PhD retweeted
CEB Cambridge@cebcambridge·Feb 27

Artificial intelligence has been used to uncover hidden allergens within the trillions of microbes living in the human body, offering insight into why some people develop allergies while others do not. Full story 👇 🧪⚙️🌱🔋 #ChemicalEngineering #Biotechnology

Post attachment
Kumar Thurimella, MD PhD avatar
Kumar Thurimella, MD PhD@k00kumar·Feb 20

6/ This is part of broader work in my PhD using pLMs to uncover enzyme function in metagenomes. A related study on CAZymes is out in BMC Bioinformatics: link.springer.com/article/10…

Kumar Thurimella, MD PhD avatar
Kumar Thurimella, MD PhD@k00kumar·Feb 20

5/ We validated two hits: a V8-like serine protease from S. schleiferi (gut) and a Der f 1-like cysteine protease from T. forsythia (oral). Both drove Th2 responses in vivo, only when enzymatically active. The CP was found despite training solely on serine proteases.

Kumar Thurimella, MD PhD avatar
Kumar Thurimella, MD PhD@k00kumar·Feb 20

3/ The question was, can the conserved catalytic triad guide deep learning to find new allergens in metagenomes? We trained an MLP on ProtT5 embeddings with AFDB structural clusters augmenting training data.

MBottjer avatar
⟳ Kumar Thurimella, MD PhD retweeted
MBottjer@Mbottjer·6 Dec 2024

FTX Chapter 11 Updates - 3AC 🏹🧵 1. FTX Objects to 3AC’s $1.5B Claim Expansion FTX filed a strong objection to the 3AC Liquidators’ motion to amend claims. 3AC seeks to balloon their $120M claim to $1.5B, citing newly discovered facts. FTX calls this a baseless “do-over” attempt post-deadline. 🚨

Pearl Freier avatar
⟳ Kumar Thurimella, MD PhD retweeted
Pearl Freier@PearlF·24 Jun 2024

Very sad to read about the MIT graduate student killed by a truck on Friday when she was riding her bike in Cambridge. Minh-Thi Nguyen, 24, was a 3rd-year graduate student studying experimental physics. bostonglobe.com/2024/06/23/m… She was awarded a National Science Foundation Graduate Research Fellowship earlier this year.